Lyudmila Sverkunova Medical is categorized under Doctors in Brooklyn, NY and active since 2006.
Lyudmila Sverkunova Medical was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6219993 by the NAICS.
If you are seeking more information, feel free to contact Arina Seleznyeva, Manager at the company’s single location by writing to 3280 Nostrand Avenue # A, Brooklyn, New York NY 11229 or by phoning (718) 645-0333. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Lyudmila Sverkunova Medical |
| Contact Person: | Arina Seleznyeva, Manager |
| Address: | 3280 Nostrand Avenue # A, Brooklyn, New York 11229 |
| Phone Number: | (718) 645-0333 |
| Website Address: | sverkunovamd.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6219993 |
| Share This Business: |
Lyudmila Sverkunova Medical was started in 2006 to provide professional Doctors under the SIC code 8011 and NAICS code 6219993. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Arina Seleznyeva, Manager for inquiries that concern Lyudmila Sverkunova Medical by calling the company number (718) 645-0333, as your correspondence is most welcome. Additionally, the physical location of the single location of Lyudmila Sverkunova Medical can be found at the coordinates 40.604311,-73.942665 as well as the street address 3280 Nostrand Avenue # A in Brooklyn, New York 11229.
For its online presence, you may visit Lyudmila Sverkunova Medical’s website at sverkunovamd.com and engage with its social media outlets through on Twitter and on Facebook.